These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 2484692

  • 1. On the mechanism of NO release from sydnonimines.
    Feelisch M, Ostrowski J, Noack E.
    J Cardiovasc Pharmacol; 1989; 14 Suppl 11():S13-22. PubMed ID: 2484692
    [Abstract] [Full Text] [Related]

  • 2. Molecular aspects underlying the vasodilator action of molsidomine.
    Noack E, Feelisch M.
    J Cardiovasc Pharmacol; 1989; 14 Suppl 11():S1-5. PubMed ID: 2484685
    [Abstract] [Full Text] [Related]

  • 3. Oxygen and oxidation promote the release of nitric oxide from sydnonimines.
    Bohn H, Schönafinger K.
    J Cardiovasc Pharmacol; 1989; 14 Suppl 11():S6-12. PubMed ID: 2484701
    [Abstract] [Full Text] [Related]

  • 4. Oxygen modulation of guanylate cyclase-mediated retinal pericyte relaxations with 3-morpholino-sydnonimine and atrial natriuretic peptide.
    Haefliger IO, Anderson DR.
    Invest Ophthalmol Vis Sci; 1997 Jul; 38(8):1563-8. PubMed ID: 9224284
    [Abstract] [Full Text] [Related]

  • 5. Effect of YC-1, an NO-independent, superoxide-sensitive stimulator of soluble guanylyl cyclase, on smooth muscle responsiveness to nitrovasodilators.
    Mülsch A, Bauersachs J, Schäfer A, Stasch JP, Kast R, Busse R.
    Br J Pharmacol; 1997 Feb; 120(4):681-9. PubMed ID: 9051308
    [Abstract] [Full Text] [Related]

  • 6. Activation of soluble guanylyl cyclase by the nitrovasodilator 3-morpholinosydnonimine involves formation of S-nitrosoglutathione.
    Schrammel A, Pfeiffer S, Schmidt K, Koesling D, Mayer B.
    Mol Pharmacol; 1998 Jul; 54(1):207-12. PubMed ID: 9658207
    [Abstract] [Full Text] [Related]

  • 7. Molsidomine inhibits the chemoattractant-induced respiratory burst in human neutrophils via a no-independent mechanism.
    Ervens J, Seifert R.
    Biochem Pharmacol; 1992 Aug 18; 44(4):637-44. PubMed ID: 1324680
    [Abstract] [Full Text] [Related]

  • 8. The role of superoxide anion in the inhibitory effect of SIN-1 in thrombin-activated human platelet adhesion.
    Cardoso MH, Morganti RP, Lilla S, Murad F, De Nucci G, Antunes E, Marcondes S.
    Eur J Pharmacol; 2010 Feb 10; 627(1-3):229-34. PubMed ID: 19895807
    [Abstract] [Full Text] [Related]

  • 9. Activation of liver guanylate cyclase by paraquat: possible role of superoxide anion.
    Vesely DL, Watson B, Levey GS.
    J Pharmacol Exp Ther; 1979 Apr 10; 209(1):162-4. PubMed ID: 34715
    [Abstract] [Full Text] [Related]

  • 10. Characterization of NS 2028 as a specific inhibitor of soluble guanylyl cyclase.
    Olesen SP, Drejer J, Axelsson O, Moldt P, Bang L, Nielsen-Kudsk JE, Busse R, Mülsch A.
    Br J Pharmacol; 1998 Jan 10; 123(2):299-309. PubMed ID: 9489619
    [Abstract] [Full Text] [Related]

  • 11. [Thiol-dependent activation of guanylate cyclase by organic nitrates].
    Schröder H, Noack E.
    Z Kardiol; 1986 Jan 10; 75 Suppl 3():20-4. PubMed ID: 2879391
    [Abstract] [Full Text] [Related]

  • 12. Endothelium- and sydnonimine-induced responses of native and cultured aortic smooth muscle cells are not impaired by nitroglycerin tolerance.
    Mülsch A, Busse R, Winter I, Bassenge E.
    Naunyn Schmiedebergs Arch Pharmacol; 1989 May 10; 339(5):568-74. PubMed ID: 2570362
    [Abstract] [Full Text] [Related]

  • 13. The peroxynitrite generator, SIN-1, becomes a nitric oxide donor in the presence of electron acceptors.
    Singh RJ, Hogg N, Joseph J, Konorev E, Kalyanaraman B.
    Arch Biochem Biophys; 1999 Jan 15; 361(2):331-9. PubMed ID: 9882464
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of platelet activating factor-induced platelet aggregation by molsidomine, SIN-1, and nitrates in vitro and ex vivo.
    Gerzer R, Drummer C, Karrenbrock B, Heim JM.
    J Cardiovasc Pharmacol; 1989 Jan 15; 14 Suppl 11():S115-9. PubMed ID: 2484688
    [Abstract] [Full Text] [Related]

  • 15. Activation of purified soluble guanylate cyclase by endothelium-derived relaxing factor from intrapulmonary artery and vein: stimulation by acetylcholine, bradykinin and arachidonic acid.
    Ignarro LJ, Harbison RG, Wood KS, Kadowitz PJ.
    J Pharmacol Exp Ther; 1986 Jun 15; 237(3):893-900. PubMed ID: 2872327
    [Abstract] [Full Text] [Related]

  • 16. Tolerance and cross-tolerance between SIN-1 and nitric oxide in bovine coronary arteries.
    Kukovetz WR, Holzmann S.
    J Cardiovasc Pharmacol; 1989 Jun 15; 14 Suppl 11():S40-6. PubMed ID: 2484698
    [Abstract] [Full Text] [Related]

  • 17. SIN-1 stimulates the production of cyclic GMP but not cyclic AMP in porcine aortic endothelial cells.
    Schini VB, Vanhoutte PM.
    J Cardiovasc Pharmacol; 1989 Jun 15; 14 Suppl 11():S91-4. PubMed ID: 2484708
    [Abstract] [Full Text] [Related]

  • 18. Increased guanylate cyclase activity is associated with an increase in cyclic guanosine 3',5'-monophosphate in left ventricular hypertrophy.
    Sadoff JD, Scholz PM, Tse J, Weiss HR.
    J Clin Invest; 1996 Aug 01; 98(3):838-45. PubMed ID: 8698876
    [Abstract] [Full Text] [Related]

  • 19. [Comparison of the effects of SIN-1, sodium nitroprusside and nitrate derivatives on the inhibition of blood platelet aggregation and activation of soluble platelet guanylate-cyclase].
    Karrenbrock B, Grewe R, Loeschke K, Gerzer R.
    Pathol Biol (Paris); 1987 Feb 01; 35(2 Pt 2):251-4. PubMed ID: 2882462
    [Abstract] [Full Text] [Related]

  • 20. Exogenous nitric oxide reduces oxygen consumption of isolated ventricular myocytes less than other forms of guanylate cyclase stimulation.
    Gong GX, Weiss HR, Tse J, Scholz PM.
    Eur J Pharmacol; 1998 Mar 05; 344(2-3):299-305. PubMed ID: 9600666
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.